Canary Staked INJ ETF shares have begun trading on Nasdaq under the ticker INJC, opening a new regulated route for investors seeking exposure to Injective’s native INJ token. The product combines two elements: the price performance of INJ held by the trust and potential rewards generated by staking a portion of those holdings on the Injective network.
Canary Capital announced the launch on November 5, describing INJC as the first U.S. spot staked INJ ETF. The fund is designed for investors who want access through a standard brokerage account rather than through an exchange account, self-custody wallet or direct interaction with the Injective blockchain.
The core proposition is straightforward: INJC holds INJ, seeks to stake much of that INJ and reflects net staking rewards in the fund’s daily net asset value, or NAV. But investors should not confuse this with receiving INJ staking rewards directly in their own wallets. Shareholders own ETF shares, and any value from staking is intended to be reflected in the value of the fund after applicable fees and expenses.
How the Canary Staked INJ ETF Works
The Canary Staked INJ ETF seeks to provide exposure to the market price of INJ held by the trust, less operating expenses and other liabilities. Its secondary objective is to earn additional INJ by participating in Injective’s proof-of-stake validation process.
Proof-of-stake networks rely on tokens being committed to validators that help secure the network and process transactions. In return, the network can distribute token rewards. INJ is used in the Injective ecosystem for staking, governance and transaction-related functions.
Canary’s prospectus says the trust expects to stake at least 90% of its INJ holdings under normal conditions. A portion may remain unstaked to support creations, redemptions, liquidity needs and other operational requirements.
That operational flexibility is important. A fund cannot necessarily stake every token at every moment if it must meet redemption requests from authorized participants or maintain liquidity for expenses. The percentage staked may therefore vary over time based on market conditions, validator performance, network rules and management decisions.
The fund’s digital-asset custodian is BitGo Bank & Trust, while Luganodes is listed as the staking provider. U.S. Bank National Association is the cash custodian, and U.S. Bank Global Fund Services serves as administrator.
Staking Rewards Are Reflected in NAV, Not Paid Out Directly
The main differentiator between INJC and a non-staking token product is the staking component. Canary says net staking rewards are reflected in the trust’s NAV rather than being issued directly to shareholders.
This means an INJC holder does not receive recurring INJ token deposits in a personal wallet. Instead, the fund’s staked holdings may earn additional INJ, and those net rewards may increase the assets backing each ETF share.
The phrase “net” matters. The fund’s prospectus says staking fees—including fees associated with the sponsor, staking provider and custodian—will reduce the rewards received by the trust. The aggregate staking fees are capped at 30% of staking rewards, and the prospectus states that they are expected to equal 30% of the rewards generated by the staking program.
In practical terms, if the staking program generates 100 INJ in rewards, the structure anticipates that the trust would retain roughly 70 INJ after the stated staking-fee share, before considering the separate sponsor fee and other fund expenses.
The ETF also charges a 1.10% annual sponsor fee. That fee is distinct from the staking-fee arrangement and should be considered when investors evaluate whether the convenience of an ETF structure outweighs the cost of direct ownership.
INJC Gives Brokerage Investors a Different Way to Access INJ
For investors, INJC removes several practical requirements associated with holding INJ directly. They do not need to open an account with a crypto exchange, manage wallet addresses, safeguard private keys, choose a validator or handle network-specific staking mechanics themselves.
Canary Capital CEO Steven McClurg said the product is designed to combine exposure to a finance-focused blockchain with a familiar investment wrapper.
“The Canary Staked INJ ETF gives investors access to a blockchain purpose-built for finance through a familiar exchange-traded structure, while also enabling investors to benefit from potential staking rewards,” McClurg said.
That convenience comes with trade-offs. ETF investors do not hold the underlying INJ themselves, cannot use the token for governance and cannot transfer ETF shares onto the Injective network. They are also exposed to the market behavior of ETF shares, which can trade at a premium or discount to NAV.
The structure may be useful for investors who prefer tax-advantaged accounts, institutional custody arrangements or traditional brokerage access. But it is not a replacement for direct network participation.
Why the Launch Matters for Injective
Injective is positioning itself as blockchain infrastructure for trading, derivatives, tokenization and financial applications. It includes an onchain order-book module and supports applications designed around financial markets.
The INJC launch gives Injective a new distribution channel: regulated market participants can gain INJ exposure through Nasdaq without directly interacting with the chain.
This is especially notable because Injective has been working to make its case in U.S. policy discussions. Bitnxt recently reported on Injective’s tokenization outreach to U.S. policymakers, where company representatives discussed tokenization and blockchain-market infrastructure with SEC Crypto Task Force staff.
An ETF launch does not validate every aspect of a blockchain’s business model or guarantee greater adoption. However, it can broaden access to investors who are unable or unwilling to hold and stake tokens directly.
INJC also arrives amid wider experimentation with regulated crypto investment products, tokenized equities and blockchain-based market infrastructure. Bitnxt has covered Morgan Stanley’s tokenized-equities plans and Robinhood’s tokenized-stock activity, both of which reflect growing interest in bringing conventional market access and blockchain rails closer together.
Risks Investors Should Not Ignore
The launch does not remove the risks associated with INJ. The value of INJC will remain heavily dependent on the token’s market price, which can move sharply with crypto-market conditions, network adoption, liquidity and broader investor sentiment.
Staking also introduces additional considerations. Validator performance, network reward rates, protocol changes, slashing-related risks and unstaking restrictions can affect the amount of rewards earned and the fund’s ability to manage liquidity.
The projected staking return is not fixed. Canary’s own fund materials state that net staking yield can vary based on validator performance, network incentives and other conditions. Investors should not read a staking ETF as a guaranteed-income product.
There is also a structural difference between owning INJ and owning INJC. Direct holders control their own tokens and can select wallets or validators, but must manage private keys and operational risk. INJC holders gain a simplified brokerage format, but rely on the fund’s sponsor, custodians, staking provider and ETF-market mechanics.
Bitnxt Take: A Useful Product, but the Fee Stack Matters
From Bitnxt’s view, INJC is meaningful because it adds staking exposure to an exchange-traded INJ product rather than offering token-price exposure alone. That could appeal to investors who want an easier path to Injective exposure without handling wallets and validator delegation themselves.
However, the fee structure deserves close attention. The 1.10% sponsor fee, plus staking fees that can take up to 30% of rewards, means investors should evaluate net results rather than focusing only on headline staking yields.
The launch may help introduce Injective to brokerage investors, but it does not eliminate volatility or transform INJ into a low-risk asset. The most useful question for prospective buyers is not simply whether INJC offers staking. It is whether the convenience, custody structure and potential net reward profile justify owning the ETF instead of holding INJ directly.
For now, INJC stands as another sign that crypto investment products are becoming more specialized. The next data points to watch are trading liquidity, asset inflows, the actual percentage of assets staked and the net staking yield after fees.
